Inventor · disambiguated record
Shota Kikuchi
Also filed as: KIKUCHI SHOTA
19 granted patents·8 pending applications·39 citations·filing 2013–2024
92Inventor score
Files withTAKEDA PHARMACEUTICALS CO12VIVIDION THERAPEUTICS INC8ENVOY THERAPEUTICS INC2TAKEDA PHARMACEUTICAL2BROWN JASON W1
Top patents by PatentIndex Score
27 records- 0188US9303045B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Apr 5, 2016·7 cites·11 claims
- 0287US9012447B25-HT3 receptor antagonistsENVOY THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·8 cites·15 claims
- 0386US9346829B25-HT3 receptor antagonistsHITCHCOCK STEPHEN·Filed 2015·Granted May 24, 2016·5 cites·2 claims
- 0485US9670229B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·3 cites·11 claims
- 0584US9770452B2Quinoxaline derivatives as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·4 cites·22 claims
- 0680US9487526B2Quinoxaline derivatives as GPR6 modulatorsENVOY THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·5 cites·21 claims
- 0777US10179783B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 15, 2019·2 cites·8 claims
- 0875US10077266B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 18, 2018·1 cites·11 claims
- 0971US9708313B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsBROWN JASON W·Filed 2015·Granted Jul 18, 2017·1 cites·15 claims
- 1071US2025188040A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1170US9181249B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Nov 10, 2015·1 cites·19 claims
- 1269US12187685B2Pharmaceutical compositions comprising WRN helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·23 claims
- 1369US10738046B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 11, 2020·0 cites·21 claims
- 1469US2024067612A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1568US10597392B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICAL CORPORATION LTD·Filed 2018·Granted Mar 24, 2020·1 cites·11 claims
- 1668US10407443B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 1768US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 1865US10125145B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 1963US2018072758A15ht3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2062US9695195B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 4, 2017·0 cites·9 claims
- 2161US10406157B2Tetrahydropyridopyrazine modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·28 claims
- 2261US2025011291A1Keap1 inhibitors and uses thereofVIVIDION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2361US2025332156A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2461US2024226114A1Inhibitors and uses thereofVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2559US2024270705A1Compounds selective for jak1 and methods of useVIVIDION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2651US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 2742US2023045737A1Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitmentVIVIDION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shota Kikuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →